# A Study of CM310 in Subjects With Moderate to Severe Asthma

> **NCT05186909** · PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 52 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CM310
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05186909
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-12
- **Primary completion:** 2023-09-13
- **Final completion:** 2023-09-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186909, "A Study of CM310 in Subjects With Moderate to Severe Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05186909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*